H.C. Wainwright Maintains Aquestive Therapeutics(AQST.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsDec 20 13:31 ET · Ratings

Aquestive Therapeutics Gains Buy Rating Amid Orphan Drug Exclusivity and Promising Product Pipeline

TipRanksDec 20 13:25 ET · Ratings

Lake Street Reaffirms Their Buy Rating on Aquestive Therapeutics (AQST)

TipRanksDec 20 12:49 ET · Ratings

Express News | HC Wainwright & Co. Reiterates Buy on Aquestive Therapeutics, Maintains $10 Price Target

BenzingaDec 20 07:42 ET

Sector Update: Health Care Stocks Lower Thursday Afternoon

MT NewswiresDec 19 13:49 ET

Aquestive Therapeutics Receives U.S. FDA Orphan Drug Exclusivity For Libervant Buccal Film In Pediatric Patients With Seizure Clusters Ages 2-5

BenzingaDec 19 08:09 ET